CTC Capital Management »

Lineage Cell Therapeutics In shares owned by CTC Capital Management

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by CTC Capital Management from 13F filings

Historical chart of CTC Capital Management investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by CTC Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by CTC Capital Management

Quarter filed Position value Share count Share price at filing
2023-03-31 $21k 14k 1.50

More positions owned by CTC Capital Management

Ishares Tr Iboxx Inv Cp Etf (LQD)
Ferguson SHS (FERG)
Select Sector Spdr Tr Financial (XLF)
Mastercard Incorporated Cl A (MA)
Yamana Gold
Coupang Cl A (CPNG)
Lattice Semiconductor (LSCC)
Cnh Indl N V SHS (CNHI)
Copart (CPRT)
Paccar (PCAR)
Ross Stores (ROST)
NetApp (NTAP)
Te Connectivity SHS (TEL)
Builders FirstSource (BLDR)
S&p Global (SPGI)

View all positions for CTC Capital Management

Top funds holding Lineage Cell Therapeutics In

Vanguard Group
Defender Capital
Raffles Associates
Prescott General Partners
MAI Wealth Advisors
Jpmorgan Chase & Co
Citadel Advisors
Laurion Capital Management
Charles Schwab Investment Management
Bank of New York Mellon
Long Focus Capital Management
Barclays
Royal Bank of Canada
Squarepoint Ops
Jane Street

View all funds holding Lineage Cell Therapeutics In